Key Points Tilray posted record revenue and adjusted EBITDA for its just-completed fiscal year, but shares continue to tumble, with Tilray down nearly 56% year to date. Two factors drive Tilray's continued decline: too little of overall revenue comes from recreational cannabis, plus the company's unresolved share dilution problem. As these issues persist, and Tilray has scant exposure to the U.S. recreational market, expect the downward spiral to continue unabated. 10 stocks we like better than Tilray Brands › Even among marijuana stocks, Tilray Brands (NASDAQ: TLRY) has performed poorly year to date. Since January, the stock has fallen by nearly 56%. Over the past five years, on a split-adjusted basis, Tilray shares have fallen by over 96.7%.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.